During the past decade, René Olivier Casasnovas conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "René Olivier Casasnovas" are "Lymphoma, B-Cell" (1 trials), "Lymphoma, Large-Cell, Diffuse" (1 trials) and "Peripheral T Cell Lymphoma" (1 trials). Many other conditions were trialed in "René Olivier Casasnovas" in a lesser frequency.

Most popular intervention types in "René Olivier Casasnovas" are "Drug" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Chemotherapy + ASCT + follow up" (1 trials), "Chemotherapy + follow up" (1 trials), "R-ACVBP14 induction regimen" (1 trials) and "R-CHOP14 induction regimen" (1 trials). Other intervention names were less common.

The vast majority of trials in "René Olivier Casasnovas" are 2 trials for "All" genders.

Currently, there are NaN active trials in "René Olivier Casasnovas". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in René Olivier Casasnovas, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in René Olivier Casasnovas, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".